<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 60-year-old Japanese patient with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) who developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with Ph negative <z:mp ids='MP_0004026'>monosomy</z:mp> 7 chromosome following transient bone marrow <z:mpath ids='MPATH_589'>dysplasia</z:mpath> during <z:chebi fb="0" ids="45783">imatinib</z:chebi> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Most cases that developed chromosomal abnormality in Ph negative cells during <z:chebi fb="0" ids="45783">imatinib</z:chebi> therapy were reported to have less clinical implications, while rare cases developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The present case suggested that metaphase karyotype analysis and bone marrow examination should be performed for the long term follow-up under <z:chebi fb="0" ids="45783">imatinib</z:chebi> treatment in cases showing cytopenia </plain></SENT>
<SENT sid="3" pm="."><plain>The results also suggested that <z:mp ids='MP_0004026'>monosomy</z:mp> 7 in Ph negative cells may be an indicator of a poor prognosis </plain></SENT>
</text></document>